Literature DB >> 11280624

Daily classification of the level of care. A method to describe clinical course of illness, use of resources and quality of intensive care assistance.

G Iapichino1, D Radrizzani, G Bertolini, L Ferla, G Pasetti, A Pezzi, F Porta, D R Miranda.   

Abstract

OBJECTIVE: To develop a simple and comparable clinical method able to distinguish between higher and lower complexities of care in the ICU.
DESIGN: Retrospective analysis.
SETTING: Database of European ICUs Study I (Euricus-I: including 12,615 patients and 55,464 patient/days), prospectively collected in 89 ICUs of 12 European countries. METHODS AND
RESULTS: A panel of experts developed the classification of the complexity of care. Six (in addition to monitoring, two levels of respiratory support--R and r--two levels of circulatory support--C and c--and dialysis) out of the nine items of Nine Equivalents of Nursing Manpower use Score (NEMS), a therapeutic index, were utilised. Two levels of care (LOCs) were defined according to a more (HT) and a less complex (LT) combination of common activities of care. The two LOCs were significantly related to mortality: higher in HT and they rose with increasing cumulative number of HT days. HT accounted for 31,976 NEMS days (57.7%) while 23,488 (42.3 %) were LT. Major respiratory and cardiovascular support accounted for about 80 % of the HT days. Respiratory assistance and monitoring were responsible for an equivalent percentage of LT days. The distribution of the clinical classification of LOCs coincided with that of the managerial scores of LOCs in the literature.
CONCLUSIONS: The managerial instrument described uses simple and reliable clinical data. It is able to distinguish between patients with different severity and outcome, and shows that every additional consecutive day spent in ICU as HT increases the probability of death. Moreover, (1) it suggests the possibility of describing the clinical course of illness by relating the complexity/level of medical care to the available technology and staff; (2) using relevant markers of clinical activity, it might be useful to include in quality control programmes.

Entities:  

Mesh:

Year:  2001        PMID: 11280624     DOI: 10.1007/s001340000776

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  11 in total

1.  Recommendations on basic requirements for intensive care units: structural and organizational aspects.

Authors:  Andreas Valentin; Patrick Ferdinande
Journal:  Intensive Care Med       Date:  2011-09-15       Impact factor: 17.440

2.  Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial.

Authors:  Guido Bertolini; Gaetano Iapichino; Danilo Radrizzani; Rebecca Facchini; Bruno Simini; Paola Bruzzone; Giancarlo Zanforlin; Gianni Tognoni
Journal:  Intensive Care Med       Date:  2003-04-09       Impact factor: 17.440

3.  Volume of activity and occupancy rate in intensive care units. Association with mortality.

Authors:  Gaetano Lapichino; Luciano Gattinoni; Danilo Radrizzani; Bruno Simini; Guido Bertolini; Luca Ferla; Giovanni Mistraletti; Francesca Porta; Dinis R Miranda
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

4.  Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.

Authors:  Jörg Martin; Anja Heymann; Katrin Bäsell; Ralf Baron; Rolf Biniek; Hartmut Bürkle; Peter Dall; Christine Dictus; Verena Eggers; Ingolf Eichler; Lothar Engelmann; Lars Garten; Wolfgang Hartl; Ulrike Haase; Ralf Huth; Paul Kessler; Stefan Kleinschmidt; Wolfgang Koppert; Franz-Josef Kretz; Heinz Laubenthal; Guenter Marggraf; Andreas Meiser; Edmund Neugebauer; Ulrike Neuhaus; Christian Putensen; Michael Quintel; Alexander Reske; Bernard Roth; Jens Scholz; Stefan Schröder; Dierk Schreiter; Jürgen Schüttler; Gerhard Schwarzmann; Robert Stingele; Peter Tonner; Philip Tränkle; Rolf Detlef Treede; Tomislav Trupkovic; Michael Tryba; Frank Wappler; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2010-02-02

5.  Determinants of post-intensive care mortality in high-level treated critically ill patients.

Authors:  Gaetano Iapichino; Alberto Morabito; Giovanni Mistraletti; Luca Ferla; Danilo Radrizzani; Dinis Reis Miranda
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

6.  Intensive care reimbursement practices: results from the ICUFUND survey.

Authors:  Akos Csomos; Szilard Varga; Guido Bertolini; Clare Hibbert; Janos Sandor; Maurizia Capuzzo; Bertrand R Guidet
Journal:  Intensive Care Med       Date:  2010-05-28       Impact factor: 17.440

7.  Variability in outcome and resource use in intensive care units.

Authors:  Hans U Rothen; Kay Stricker; Johanna Einfalt; Peter Bauer; Philip G H Metnitz; Rui P Moreno; Jukka Takala
Journal:  Intensive Care Med       Date:  2007-06-01       Impact factor: 41.787

8.  Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis.

Authors:  David L Edbrooke; Cosetta Minelli; Gary H Mills; Gaetano Iapichino; Angelo Pezzi; Davide Corbella; Philip Jacobs; Anne Lippert; Joergen Wiis; Antonio Pesenti; Nicolo Patroniti; Romain Pirracchio; Didier Payen; Gabriel Gurman; Jan Bakker; Jozef Kesecioglu; Chris Hargreaves; Simon L Cohen; Mario Baras; Antonio Artigas; Charles L Sprung
Journal:  Crit Care       Date:  2011-02-09       Impact factor: 9.097

9.  Pandemic influenza and excess intensive-care workload.

Authors:  Raoul E Nap; Maarten P H M Andriessen; Nico E L Meessen; Dinis dos Reis Miranda; Tjip S van der Werf
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

10.  Enteral vs. intravenous ICU sedation management: study protocol for a randomized controlled trial.

Authors:  Giovanni Mistraletti; Elena S Mantovani; Paolo Cadringher; Barbara Cerri; Davide Corbella; Michele Umbrello; Stefania Anania; Elisa Andrighi; Serena Barello; Alessandra Di Carlo; Federica Martinetti; Paolo Formenti; Paolo Spanu; Gaetano Iapichino
Journal:  Trials       Date:  2013-04-03       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.